相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Prediction of one- and two-year mortality after transcatheter aortic valve implantation: proposal of a fast sum-score system integrating a novel biomarker of cardiac extracellular matrix accumulation and fibrosis
Laura Baez et al.
REVIEWS IN CARDIOVASCULAR MEDICINE (2022)
Epigenetic Mechanism and Therapeutic Implications of Atrial Fibrillation
Dan Li et al.
FRONTIERS IN CARDIOVASCULAR MEDICINE (2022)
Atrial Fibrillation and Depression: A Bibliometric Analysis From 2001 to 2021
Yuzhen Ai et al.
FRONTIERS IN CARDIOVASCULAR MEDICINE (2022)
Total NT-proBNP, a novel biomarker related to recurrent atrial fibrillation
Lidia Staszewsky et al.
BMC CARDIOVASCULAR DISORDERS (2021)
Catheter ablation or medical therapy to delay progression of atrial fibrillation: the randomized controlled atrial fibrillation progression trial (ATTEST)
Karl-Heinz Kuck et al.
EUROPACE (2021)
Atrial fibrosis underlying atrial fibrillation (Review)
Chang Yi Li et al.
INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE (2021)
A Review of the Molecular Mechanisms Underlying Cardiac Fibrosis and Atrial Fibrillation
Grazyna Sygitowicz et al.
JOURNAL OF CLINICAL MEDICINE (2021)
Atrial Fibrillation
Jayson R. Baman et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2021)
C-reactive protein for prediction of atrial fibrillation recurrence after catheter ablation
Pascal B. Meyre et al.
BMC CARDIOVASCULAR DISORDERS (2020)
The Predictive Value of Growth Differentiation Factor-15 in Recurrence of Atrial Fibrillation after Catheter Ablation
Ying Wei et al.
MEDIATORS OF INFLAMMATION (2020)
Reduced left atrial cardiomyocyte PITX2 and elevated circulating BMP10 predict atrial fibrillation after ablation
Jasmeet S. Reyat et al.
JCI INSIGHT (2020)
Atrial matrix remodeling in atrial fibrillation patients with aortic stenosis
Mariana Fragao-Marques et al.
BMC CARDIOVASCULAR DISORDERS (2020)
Biomarkers Determining Prognosis of Atrial Fibrillation Ablation
Dimitris Tsiachns et al.
CURRENT MEDICINAL CHEMISTRY (2019)
Chromosome 4q25 variants and biomarkers of myocardial fibrosis in patients with atrial fibrillation
Jong-Il Choi et al.
JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY (2019)
Soluble ST2 in Paroxysmal Atrial Fibrillation: a New Biomarker that Predicts Recurrence?
Ahmed AlTurki
KOREAN CIRCULATION JOURNAL (2018)
Catheter Ablation of Atrial Fibrillation: An Overview for Clinicians
Nebojsa Mujovic et al.
ADVANCES IN THERAPY (2017)
The serum matrix metalloproteinase-9 level is an independent predictor of recurrence after ablation of persistent atrial fibrillation
Gang Wu et al.
CLINICS (2016)
Inflammation and the pathogenesis of atrial fibrillation
Yu-Feng Hu et al.
NATURE REVIEWS CARDIOLOGY (2015)
Markers of Collagen Synthesis, Atrial Fibrosis, and the Mechanisms Underlying Atrial Fibrillation
Jonathan M. Kalman et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2012)
High Plasma Concentrations of Transforming Growth Factor-β and Tissue Inhibitor of Metalloproteinase-1-Potential Non-Invasive Predictors for Electroanatomical Remodeling of Atrium in Patients With Non-Valvular Atrial Fibrillation
Sook Kyoung Kim et al.
CIRCULATION JOURNAL (2011)
Time course of markers of tissue repair after ablation of atrial fibrillation and their relation to left atrial structural changes and clinical ablation outcome
Bernhard Richter et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2011)
Association between C-reactive protein and recurrence of atrial fibrillation after successful electrical cardioversion - A meta-analysis
Tong Liu et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2007)
Is thrombogenesis in atrial fibrillation related to matrix metalloproteinase-1 and its inhibitor, TIMP-1?
F Marín et al.
STROKE (2003)